NMN for Fertility and Egg Quality: What the Evidence Shows

NMN (nicotinamide mononucleotide) and other NAD+ precursors are increasingly marketed to women trying to conceive — especially women in their late 30s and 40s, and women heading into IVF. The pitch is seductive: "restore your NAD+, rejuvenate your eggs." The underlying biology is real and genuinely interesting. But the honest headline, stated up front, is the one the marketing buries: the impressive fertility results are almost entirely from mice and cell-culture dishes, and there is no robust human trial showing that taking NMN or NAD+ improves egg quality, ovarian reserve, or live-birth rates. This page walks through exactly what is proven, what is preclinical, and where the evidence runs out.

Two framing points to keep throughout. First, NMN and nicotinamide riboside (NR) are sold as dietary supplements, not approved fertility drugs — none is FDA-approved to treat infertility or improve egg quality. Second, and most important for anyone trying to conceive: NAD+ precursors are essentially unstudied in pregnancy and during conception, so this is not a "can't hurt to try" supplement.

Why NAD+ is even in the fertility conversation

The biology that put NAD+ on the fertility map is legitimate. NAD+ is a coenzyme central to energy metabolism and DNA repair, and tissue levels decline with age across the body ¹. The egg (oocyte) is one of the most energy-hungry cells in the body, and its developmental competence depends heavily on healthy mitochondria. As women age, oocyte mitochondrial function declines — and that decline is one of the best-described drivers of falling egg quality and the steep drop in fertility through the late 30s and 40s ². Reviews of ovarian aging place NAD+ decline squarely inside that picture: less NAD+ means less fuel for the NAD+-dependent sirtuins and PARPs that oocytes rely on for energy and DNA repair ³.

So the rationale isn't fabricated. Falling NAD+ plausibly contributes to ovarian aging, and topping it up might help. The question is whether "might" has been turned into "does" — and in humans, it hasn't.

The striking mouse data (and why it went viral)

The fertility excitement traces to one landmark animal study. Researchers gave the NAD+ precursor NMN to reproductively aged female mice and reported that NAD+ repletion restored egg quality and improved fertility outcomes — better oocyte quality, better embryo development, and more pups in aged animals ⁴. That result is genuinely remarkable, and it's why "NAD+ for egg quality" became a fertility-clinic talking point almost overnight.

It is not an isolated finding, either. Multiple independent animal and cell-culture studies have reported that NAD+ precursors protect oocytes from age-related decline: NR slowed the quality decline of post-ovulatory ("aged") eggs in mouse and in-vitro models ⁵⁶, and a 2025 review summarizing this literature concluded that NAD+ precursors "mitigate" reproductive defects across in-vitro and in-vivo animal systems ⁷. As a body of preclinical work, the signal is real and consistent.

But notice the word in every one of those sentences: animal, mouse, in-vitro. That same 2025 review is blunt about the translation gap — it discusses delivery strategies that "[have] not yet been investigated in literature" and presents no human clinical evidence ⁷. Mouse fertility results are notoriously difficult to translate to women, and a striking effect in aged mice is a hypothesis to test in humans, not a benefit you can buy.

What human data actually exist — and what they don't

Here's where honesty matters most. Search the human literature for "NMN improves egg quality" or "NAD+ supplement raised IVF success," and you will not find a randomized controlled trial — or even a solid retrospective cohort — answering that question. What exists in humans is narrower and more indirect:

• •Mechanistic confirmation in women. A 2025 proteomics study of ovarian granulosa cells from infertile women under 35 with diminished ovarian reserve found that the most-disrupted pathway was oxidative phosphorylation — i.e., mitochondrial energy production — confirming that the mitochondrial-dysfunction story the mouse work targets is real in human ovaries too ⁸. That validates the target. It does not show that an NMN capsule fixes it.
• •Proof precursors raise NAD+ in women. NMN reliably raises NAD+ and improved muscle insulin sensitivity in a randomized trial of postmenopausal, prediabetic women ⁹. So we know oral NMN "works" as an NAD+-raising supplement in women — but that trial was about metabolism, not reproduction, and postmenopausal women are not the fertility-target population.

Put those together and the human picture is: the biological target is confirmed, the supplement provably raises NAD+ — but no study has closed the loop and shown improved eggs, embryos, pregnancies, or babies in women. That missing link is the entire ballgame for a fertility claim, and it is empty.

A fairer comparison: what a *human-evidenced* egg supplement looks like

It helps to contrast NMN with a supplement that actually has human fertility data, to show the gap. Coenzyme Q10 (CoQ10) — another mitochondrial-support compound — has been tested in randomized trials and meta-analyzed in women with diminished ovarian reserve undergoing IVF/ICSI, with reviews reporting improvements in some ovarian-response and embryo metrics ¹⁰. CoQ10's evidence is itself modest and debated, and it is not proof that NMN works — but it shows what the bar looks like: actual trials in actual IVF patients with actual reproductive endpoints. NMN has not cleared that bar; CoQ10 has at least approached it. If you're going to spend on a mitochondrial "egg quality" supplement, that difference in evidence is worth knowing.

Safety: the reason "it probably can't hurt" is the wrong frame

For most general-wellness uses, oral NMN and NR are well tolerated, with mostly mild side effects in the trials that exist ⁹. But fertility is a special case for two reasons:

1. 1.Pregnancy is unstudied. NAD+ precursors have essentially no human safety data in pregnancy or during conception. Because women using these supplements for fertility are, by definition, trying to become pregnant, you can be taking an unstudied compound at the exact moment of conception and early embryo development. That is the opposite of a low-stakes supplement.
2. 2.You may be spending real money on a hope. Women pursuing fertility — often while paying out of pocket for IVF — deserve to know they would be acting on preclinical (mouse) data, not proven human outcomes. The opportunity cost (money, and time on the fertility clock) is real.

Anyone considering NMN for fertility should treat it as experimental and discuss it with their reproductive endocrinologist rather than self-prescribing — particularly before or during an IVF cycle, where it could interact with a carefully managed protocol.

The honest bottom line

NAD+ biology is a legitimate target in ovarian aging: oocyte mitochondria decline with age ², NAD+ falls with age ¹, and human ovarian tissue from women with diminished reserve shows exactly the mitochondrial disruption the theory predicts ⁸. The animal evidence that NMN can restore egg quality in aged mice is striking and consistent ⁴⁵⁶⁷. But not one human trial has shown that taking NMN or NAD+ improves egg quality, ovarian reserve, or pregnancy outcomes — and the compound is unstudied in pregnancy. So NMN for fertility belongs firmly in the "experimental, mechanism-plausible, human-unproven" column. It is a hypothesis under study, not a buyable benefit — and not a substitute for evidence-based fertility care.

For the broader evidence picture, start with our pillar guide, NAD+ therapy: the evidence, and our honest take on whether NAD+ is really anti-aging. For the wider women's-health claims around NAD+ — menopause, energy, skin and more — see NAD+ for women. And to compare specific products on dose, form and third-party testing, see our NAD+ rankings hub and our best NMN supplements guide.

This is consumer education, not medical advice. NMN and NAD+ precursors are dietary supplements, not FDA-approved fertility treatments, and are essentially unstudied in pregnancy. If you are trying to conceive, pregnant, undergoing fertility treatment, or considering any supplement during an IVF cycle, talk to your reproductive endocrinologist first.